Jeffrey Krieger

1.2k total citations
16 papers, 989 citations indexed

About

Jeffrey Krieger is a scholar working on Immunology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Jeffrey Krieger has authored 16 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 3 papers in Molecular Biology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Jeffrey Krieger's work include T-cell and B-cell Immunology (10 papers), Immunotherapy and Immune Responses (9 papers) and Immune Cell Function and Interaction (9 papers). Jeffrey Krieger is often cited by papers focused on T-cell and B-cell Immunology (10 papers), Immunotherapy and Immune Responses (9 papers) and Immune Cell Function and Interaction (9 papers). Jeffrey Krieger collaborates with scholars based in United States, France and Slovakia. Jeffrey Krieger's co-authors include M. Schmied, Petra W. Duda, David A. Hafler, H M Grey, Robert W. Chesnut, Susan F. Grammer, John Sidney, Robert W. Karr, D A Hafler and Donal M. O’Sullivan and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and PLoS ONE.

In The Last Decade

Jeffrey Krieger

16 papers receiving 961 citations

Peers

Countries citing papers authored by Jeffrey Krieger

Since Specialization

Citations

This map shows the geographic impact of Jeffrey Krieger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Krieger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Krieger more than expected).

Fields of papers citing papers by Jeffrey Krieger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Krieger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Krieger. The network helps show where Jeffrey Krieger may publish in the future.

Co-authorship network of co-authors of Jeffrey Krieger

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Krieger. A scholar is included among the top collaborators of Jeffrey Krieger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Krieger. Jeffrey Krieger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Macrophage-Specific Chemokines Induced via Innate Immunity by Amino Acid Copolymers and Their Role in EAE 2011 ·PLoS ONE ·Joseph Kovalchin, Jeffrey Krieger, (unknown), Norio Kawamoto, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jack L. Strominger, Eric Zanelli	8
2	Results of a phase I study in patients suffering from secondary-progressive multiple sclerosis demonstrating the safety of the amino acid copolymer PI-2301 and a possible induction of an anti-inflammatory cytokine response 2010 ·Journal of Neuroimmunology ·Joseph Kovalchin, Jeffrey Krieger, (unknown), (unknown), (unknown), (unknown), (unknown), Bernice Kuca, Gilles Edan, Cécile Braudeau, Marie Rimbert, Uday Patel, E A Mascioli, Eric Zanelli	10
3	Safety, Pharmacokinetic, and Pharmacodynamic Evaluations of PI-2301, a Potent Immunomodulator, in a First-in-Human, Single-Ascending-Dose Study in Healthy Volunteers 2010 ·The Journal of Clinical Pharmacology ·Joseph Kovalchin, Jeffrey Krieger, (unknown), (unknown), (unknown), (unknown), Tony Avril, (unknown), Alain Patat, (unknown), (unknown), Eric Lacoste, Uday Patel, Edward A. Mascioli, Eric Zanelli	8
4	In vitro evidence that subcutaneous administration of glatiramer acetate induces hyporesponsive T cells in patients with multiple sclerosis 2003 ·Clinical Immunology ·M. Schmied, Petra W. Duda, Jeffrey Krieger, Christina Trollmo, David A. Hafler	21
5	In vitro immunomodulatory activity of ruthenium complexes 2003 ·Inflammation Research ·John Newcomb, Benjamin Rivnay, Cecilia M. Bastos, Timothy D. Ocain, (unknown), Philip D. Gregory, Susan M. Turci, (unknown), Michael I. Jesson, Jeffrey Krieger, James C. Jenson, Barry Jones	13
6	Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN‐γ‐inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4⁺ T‐cell activation 2001 ·Glia ·Jeanne M. Soos, Jeffrey Krieger, Olaf Stüve, Chelsea King, Juan C. Patarroyo, Ken Aldape, Karolina Wosik, Anthony Slavin, Patricia A. Nelson, Jack P. Antel, Scott S. Zamvil	44
7	Human and Murine CD4 T Cell Reactivity to a Complex Antigen: Recognition of the Synthetic Random Polypeptide Glatiramer Acetate 2000 ·The Journal of Immunology ·Petra W. Duda, Jeffrey Krieger, M. Schmied, Courtney J. Balentine, David A. Hafler	67
8	Glatiramer acetate (Copaxone®) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis 2000 ·Journal of Clinical Investigation ·Petra W. Duda, M. Schmied, (unknown), Jeffrey Krieger, David A. Hafler	328
9	Changes in cytokine secretion induced by altered peptide ligands of myelin basic protein peptide 85-99 1997 ·The Journal of Immunology ·Lara J. Ausubel, Jeffrey Krieger, D A Hafler	43
10	Definition of a DQ3.1-specific binding motif. 1994 ·The Journal of Immunology ·John Sidney, Carla Oseroff, Marika Guercio, Scott Southwood, Jeffrey Krieger, Glenn Ishioka, Kazuyasu Sakaguchi, Ettore Appella, Alessandro Sette	33
11	Human Anti-Endotoxin Antibody HA-1A Mediates Complement-Dependent Binding of Escherichia coli J5 Lipopolysaccharide to Complement Receptor Type 1 of Human Erythrocytes and Neutrophils 1993 ·The Journal of Infectious Diseases ·Jeffrey Krieger, (unknown), Scott A. Siegel, D T Fearon, (unknown), (unknown), Ronald P. Taylor, Peter E. Daddona	21
12	T cell receptor antagonism mediated by interaction between T cell receptor junctional residues and peptide antigen analogues 1993 ·The Journal of Immunology ·David A. Ostrov, Jeffrey Krieger, John Sidney, Alessandro Sette, Patrick Concannon	47
13	Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition 1991 ·The Journal of Immunology ·Jeffrey Krieger, Robert W. Karr, H M Grey, Wenhao Yu, Donal M. O’Sullivan, (unknown), Zhili Zheng, S M Colón, F C Gaeta, John Sidney	143
14	Studies on the capacity of intact cells and purified Ia from different B cell sources to function in antigen presentation to T cells. 1988 ·The Journal of Immunology ·Jeffrey Krieger, (unknown), Robert W. Chesnut, H M Grey	42
15	Capacity of B cells to function as stimulators of a primary mixed leukocyte reaction. 1986 ·The Journal of Immunology ·Jeffrey Krieger, Robert W. Chesnut, H M Grey	37
16	Antigen presentation by splenic B cells: resting B cells are ineffective, whereas activated B cells are effective accessory cells for T cell responses. 1985 ·The Journal of Immunology ·Jeffrey Krieger, Susan F. Grammer, H M Grey, Robert W. Chesnut	124

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact